Eligibility Criteria of Randomized Clinical Trials in Critical Care Medicine
This study examines the justification of exclusion criteria in published randomized clinical trials in critical care medicine.
Related Articles
Striking a Balance — Advancing Physician Collective-Bargaining Rights and Patient Protections | NEJM
Amid growing interest in unionization and recent strike activity among physicians, policies could be updated to better reflect the realities of modern health care and…
Lean Steatotic Liver Disease Affects 12% of US Adults, Study Finds
Based on NHANES data, the age-adjusted prevalence of lean SLD was found to be 12.8%, including a 9.8% prevalence of lean MASLD.
Junk Food Turns Public Villain as Power Shifts in Washington – KFF Health News
Some Trump insiders are ready to take on the food industry. It remains to be seen whether their entrée will result in any meaningful change…
Could Timelier Referrals for VADs Improve Outcomes in Children With CHD?
When undergoing ventricular assist device (VAD) implantation, children with congenital heart disease are more likely to experience adverse outcomes, highlights the need for a timely…
Fearing AI Will Take Their Jobs, Workers Strategize for a Long Battle Against Tech
At a landmark gathering in California, workers discussed defenses against artificial intelligence and surveillance technology.
DEA unveils telehealth rules for Adderall, buprenorphine, other controlled medications
The DEA’s long-awaited rule would allow providers on a new registry prescribe controlled medications. But there are restrictions.
RN Live – RheumNow
RheumNow Live is unlike any meeting you’ve ever attended. Here’s why: You can attend RheumNow Live in person in Irving, Texas or the comfort of…
The first-ever ransomware dropped 35 years ago disguised as a floppy sharing ‘AIDS Information’
20,000 PC Business World magazine subscribers received this 5.25-inch floppy in the mail.
Maker turns old Roomba vacuum into a Raspberry Pi-powered AI dog-feeding robot
Because keeping the floors clean wasn’t impressive enough.
Metastatic Prostatic Adenocarcinoma With Paneth Cell–Like Neuroendocrine Differentiation
A patient in his late 60s with a prior history of widely metastatic prostatic adenocarcinoma was treated with androgen deprivation therapy and docetaxel chemotherapy. On…
